Endocrinology
News, opinions and meeting coverage in endocrinology.
— Generic liraglutide approved at dosage for type 2 diabetes only
Latest in Endocrinology
It took 2 years of insurance rigamarole, but 3 months post-op, she's lost 66 pounds
However, many expect demand to come back eventually
Tirzepatide ok'd for obstructive sleep apnea in people with obesity
Antisense oligonucleotide olezarsen slashes high triglycerides
Tirzepatide ok'd for obstructive sleep apnea in people with obesity
Antisense oligonucleotide olezarsen slashes high triglycerides
Endocrinology Case Studies
Alcoholism, liver dysfunction highly linked with rare disease of unknown etiology
Surgery may not always be the best option, case report finds
Diagnosis of this rare disease is often a challenge
More in Endocrinology
Compounders only have 2 to 3 months left to copy injectable
Health news and commentary gathered by MedPage Today staff
The warning highlights known risk of rare but serious liver injury associated with fezolinetant
News and commentary from the endocrinology world
Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose
Cost, insurance coverage likely play outsized role
With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing
Also in TTHealthWatch: depression treatment after positive screening in primary care
Social support may be key to improving glycemic control, experts say
Health news and commentary gathered by MedPage Today staff
Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care
20% lower risk of VTE observed in large retrospective study of diabetes patients
Existing models improved only slightly after accounting for certain female risk factors
